LOXO292 highly selective RETinhibitor. Well tolerated with promising intracranisl efficacy

Martin Forster UCLH / UCL Cancer Institute talks about next generation #RETinhibitor #BLU667 from Blueprint Medicines in #lungcancer and #medullarythryoidcancer / #MTC at the novel #RETatCRICK meeting, 10 June, London: retatcrick.wixsite.com/retatcrick #NSCLC #endocrinology #oncology #EndocrineCancer

#Selpercatinib #thyroidcancer #RetInhibitor #cancer #tiroides ESE_President Asoc. Col. Endocrino Sociedad SEEN fausto heredia z. ENDO-Clínica Flor García Ricardosierramiguez @SAEM_tw American Thyroid Association AACE Leonardo J Rojas 📍 Fabián Pitoia, MD, Ph D Cristobal Morales

Pediatric Patients With RET-Altered #Tumors Experience Tumor Responses With Selpercatinib
bit.ly/3cqmnuH

#CancerResearch #CancerTreatment #RETinhibitor

Loxo releases positive data on LOXO-292, a drug that ... goo.gl/TUavZ6 #LoxoOncology #clinicaltrial #RETinhibitor #LOXO292

Closely following Pralsetinib, the second RET inhibitor in China was applied for production
pharmasources.com/news/74120.htm…
#pharma sources #pharma #RETinhibitor #Cancer Treatment #Cancer

Or may be we do not have yet a strong and specific RETinhibitor #LCSM x.com/jackwestmd/sta…

🎥 Next-Gen RET Inhibitor video oncologytube.com/video/42071/re… for RET-Altered Solid Tumors #KL590586 #RETinhibitor #SolidTumors #CancerResearch #ASCO23 - Qing Zhou, MD

FDA Approves Lilly's #Retevmo ® ( #selpercatinib ), the First and Only RET Inhibitor for Adults with Advanced or Metastatic Solid Tumors with a RET Gene Fusion, Regardless of Type
#RETinhibitor
prnewswire.com/news-releases/…

#FDA Approves #Lillys #Retevmo ( #Selpercatinib ) the First and Only #RETInhibitor for Adults with Advanced or #Metastatic #SolidTumors with a #RETGeneFusion Regardless of Type $LLY 1stoncology.com/blog/fda-appro…

#LungCancer trial of #RETInhibitor #Selpercatinib achieves durable responses in majority of patients with #RETGeneFusions 1stoncology.com/blog/lung-canc…

#BlueprintMedicines inks deal with #CStone #Pharmaceuticals to develop drugs in #China , including #RET inhibitor BLU-667 firstwordpharma.com/node/1570027?t… via FirstWord Pharma Blueprint Medicines #RET inhibitor #pharma #pharma news #avapritinib

#Ellipses Announces First Patient Dosed with #EP0031 , a Next Generation Selective #RETInhibitor 1stoncology.com/blog/ellipses-…

#Stemline In-Licenses Worldwide Rights to Novel Selective #RETInhibitor ( #SL1001 ); Expands #Oncology Pipeline 1stoncology.com/blog/stemline-…

#CStone receives approval in China to initiate Phase 1 clinical trial for #RETinhibitor #BLU667 ( #CS3009 ) 1stoncology.com/blog/cstone-re…

#ThermoFisher Scientific Signs Agreement with #Lilly Oncology for Companion Diagnostic to be Used with #RETInhibitor $LLY 1stoncology.com/blog/thermo-fi…

#BlueprintMedicines ' Highly Selective #RETInhibitor #BLU667 Shows Durable Anti-Tumor Activity in Patients with #RETAlteredCancers in Updated #ARROWTrial Data Presented at #ASCO19 $BPMC 1stoncology.com/blog/blueprint…

#Selpercatinib gains FDA approval as first specific treatment for metastatic #NSCLC or medullary #ThyroidCancer with #RET gene fusions. #TargetedTherapy #Oncology #RET Inhibitor #Precisionmedicine

CIRCULOGENE: One Tube, One Week, Complete Results.

medpagetoday.com/hematologyonco…